New Enterprise Associates 16, L.P. 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-27 4:34 pm Sale | 2022-05-25 | 13D | Genocea Biosciences, Inc. GNCA | New Enterprise Associates 16, L.P. | 0 0.000% | -15,414,495 (Position Closed) | Filing |
| 2021-04-13 7:08 pm Sale | 2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA | New Enterprise Associates 16, L.P. | 15,414,495 26.300% | -1,558,333 (-9.18%) | Filing |
| 2020-08-03 2:22 pm Purchase | 2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA | New Enterprise Associates 16, L.P. | 16,972,828 48.700% | 8,004,211 (+89.25%) | Filing |